{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:16:38Z","timestamp":1787850998905,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP19KK0229"],"award-info":[{"award-number":["JP19KK0229"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP21H04786"],"award-info":[{"award-number":["JP21H04786"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP21H02819"],"award-info":[{"award-number":["JP21H02819"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP21K18279"],"award-info":[{"award-number":["JP21K18279"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP22K06464"],"award-info":[{"award-number":["JP22K06464"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Normal tension glaucoma (NTG) is a progressive neurodegenerative disease in glaucoma families. Typical glaucoma develops because of increased intraocular pressure (IOP), whereas NTG develops despite normal IOP. As a subtype\u00a0of open-angle glaucoma, NTG is characterized by retinal ganglion cell (RGC) degeneration, gradual\u00a0loss of axons, and\u00a0injury to the optic nerve. The relationship between glutamate excitotoxicity and oxidative stress has elicited great interest in NTG studies. We recently reported that suppressing collapsin response mediator protein 2 (CRMP2) phosphorylation in S522A CRMP2 mutant (CRMP2 KIKI) mice inhibited RGC death in NTG mouse models. This study evaluated the impact of the natural compounds huperzine A (HupA) and naringenin (NAR), which have therapeutic effects against glutamate excitotoxicity and oxidative stress, on inhibiting CMRP2 phosphorylation in mice intravitreally injected with <jats:italic>N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate (NMDA) and GLAST mutant mice. Results of the study demonstrated that HupA and NAR significantly reduced RGC degeneration and thinning of the inner retinal layer, and inhibited the elevated CRMP2 phosphorylation. These treatments protected against glutamate excitotoxicity and suppressed oxidative stress, which could provide insight into developing new effective therapeutic strategies for NTG.<\/jats:p>","DOI":"10.1007\/s12017-024-08778-1","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:01:41Z","timestamp":1713178901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Yuebing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musukha Mala","family":"Brahma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Nolia Blanco","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuntaro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"10","key":"8778_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/nu9101161","volume":"9","author":"D Al-Dosari","year":"2017","unstructured":"Al-Dosari, D., Ahmed, M., Al-Rejaie, S., Alhomida, A., & Ola, M. (2017). Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina. Nutrients, 9(10), 1161. https:\/\/doi.org\/10.3390\/nu9101161","journal-title":"Nutrients"},{"issue":"8","key":"8778_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/gtc.12971","volume":"27","author":"MM Brahma","year":"2022","unstructured":"Brahma, M. M., Takahashi, K., Namekata, K., Harada, T., Goshima, Y., & Ohshima, T. (2022). Genetic inhibition of collapsin response mediator protein-2 phosphorylation ameliorates retinal ganglion cell death in normal-tension glaucoma models. Genes to Cells, 27(8), 526\u2013536. https:\/\/doi.org\/10.1111\/gtc.12971","journal-title":"Genes to Cells"},{"issue":"24","key":"8778_CR3","doi-asserted-by":"publisher","first-page":"16591","DOI":"10.1074\/jbc.M513344200","volume":"281","author":"AR Cole","year":"2006","unstructured":"Cole, A. R., Causeret, F., Yadirgi, G., Hastie, C. J., McLauchlan, H., McManus, E. J., Hern\u00e1ndez, F., Eickholt, B. J., Nikolic, M., & Sutherland, C. (2006). Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. Journal of Biological Chemistry, 281(24), 16591\u201316598. https:\/\/doi.org\/10.1074\/jbc.M513344200","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"8778_CR4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1471-4159.2007.04829.x","volume":"103","author":"AR Cole","year":"2007","unstructured":"Cole, A. R., Noble, W., Aalten, L. V., Plattner, F., Meimaridou, R., Hogan, D., Taylor, M., LaFrancois, J., Gunn-Moore, F., Verkhratsky, A., Oddo, S., LaFerla, F., Giese, K. P., Dineley, K. T., Duff, K., Richardson, J. C., Yan, S. D., Hanger, D. P., Allan, S. M., & Sutherland, C. (2007). Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer\u2019s disease progression. Journal of Neurochemistry, 103(3), 1132\u20131144. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04829.x","journal-title":"Journal of Neurochemistry"},{"issue":"10","key":"8778_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2016.e00191","volume":"2","author":"Z Dong","year":"2016","unstructured":"Dong, Z., Shinmei, Y., Dong, Y., Inafuku, S., Fukuhara, J., Ando, R., Kitaichi, N., Kanda, A., Tanaka, K., Noda, K., Harada, T., Chin, S., & Ishida, S. (2016). Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon, 2(10), e00191. https:\/\/doi.org\/10.1016\/j.heliyon.2016.e00191","journal-title":"Heliyon"},{"key":"8778_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3906\/sag-1406-145","volume":"45","author":"M Eraslan","year":"2015","unstructured":"Eraslan, M., \u00c7erman, E., \u00c7eki\u0307\u00e7, O., Balci, S., Deri\u0307ci\u0307o\u011flu, V., \u015eahi\u0307n, \u00d6., S\u00fcer, D., Chabou, B., & Tuncer Elmaci, E. N. (2015). Neurodegeneration in ocular and central nervous systems: Optical coherence tomography study in normal-tension glaucoma and Alzheimer disease*. Turkish Journal of Medical Sciences, 45, 1106\u20131114. https:\/\/doi.org\/10.3906\/sag-1406-145","journal-title":"Turkish Journal of Medical Sciences"},{"issue":"21","key":"8778_CR7","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.3390\/molecules26216531","volume":"26","author":"MJ Friedli","year":"2021","unstructured":"Friedli, M. J., & Inestrosa, N. C. (2021). Huperzine A and its neuroprotective molecular signaling in Alzheimer\u2019s disease. Molecules, 26(21), 6531. https:\/\/doi.org\/10.3390\/molecules26216531","journal-title":"Molecules"},{"issue":"3","key":"8778_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1167\/iovs.04-0777","volume":"46","author":"D Gherghel","year":"2005","unstructured":"Gherghel, D., Griffiths, H. R., Hilton, E. J., Cunliffe, I. A., & Hosking, S. L. (2005). Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Investigative Opthalmology & Visual Science, 46(3), 877. https:\/\/doi.org\/10.1167\/iovs.04-0777","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"2","key":"8778_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/bjophthalmol-2018-312724","volume":"103","author":"C Harada","year":"2019","unstructured":"Harada, C., Kimura, A., Guo, X., Namekata, K., & Harada, T. (2019). Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning. British Journal of Ophthalmology, 103(2), 161\u2013166. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312724","journal-title":"British Journal of Ophthalmology"},{"issue":"7","key":"8778_CR10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1172\/JCI30178","volume":"117","author":"T Harada","year":"2007","unstructured":"Harada, T., Harada, C., Nakamura, K., Quah, H.-M.A., Okumura, A., Namekata, K., Saeki, T., Aihara, M., Yoshida, H., Mitani, A., & Tanaka, K. (2007). The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. Journal of Clinical Investigation, 117(7), 1763\u20131770. https:\/\/doi.org\/10.1172\/JCI30178","journal-title":"Journal of Clinical Investigation"},{"key":"8778_CR11","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S27084","author":"S Herzon","year":"2012","unstructured":"Herzon, S., & Tun, M. K. M. (2012). The pharmacology and therapeutic potential of (-)-huperzine A. Journal of Experimental Pharmacology. https:\/\/doi.org\/10.2147\/JEP.S27084","journal-title":"Journal of Experimental Pharmacology"},{"key":"8778_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/797824","volume":"2014","author":"S Kara","year":"2014","unstructured":"Kara, S., Gencer, B., Karaca, T., Tufan, H. A., Arikan, S., Ersan, I., Karaboga, I., & Hanci, V. (2014). Protective effect of hesperetin and naringenin against apoptosis in ischemia\/reperfusion-induced retinal injury in rats. The Scientific World Journal, 2014, 1\u20138. https:\/\/doi.org\/10.1155\/2014\/797824","journal-title":"The Scientific World Journal"},{"issue":"3","key":"8778_CR13","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ajpath.2010.11.072","volume":"178","author":"M Kayama","year":"2011","unstructured":"Kayama, M., Nakazawa, T., Thanos, A., Morizane, Y., Murakami, Y., Theodoropoulou, S., Abe, T., Vavvas, D., & Miller, J. W. (2011). Heat shock protein 70 (HSP70) is critical for the photoreceptor stress response after retinal detachment via modulating anti-apoptotic Akt kinase. The American Journal of Pathology, 178(3), 1080\u20131091. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.072","journal-title":"The American Journal of Pathology"},{"key":"8778_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9539681","volume":"2020","author":"K Kikuchi","year":"2020","unstructured":"Kikuchi, K., Dong, Z., Shinmei, Y., Murata, M., Kanda, A., Noda, K., Harada, T., & Ishida, S. (2020). Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. Journal of Ophthalmology, 2020, 1\u20136. https:\/\/doi.org\/10.1155\/2020\/9539681","journal-title":"Journal of Ophthalmology"},{"issue":"1","key":"8778_CR15","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1038\/s41598-019-43658-w","volume":"9","author":"S Kondo","year":"2019","unstructured":"Kondo, S., Takahashi, K., Kinoshita, Y., Nagai, J., Wakatsuki, S., Araki, T., Goshima, Y., & Ohshima, T. (2019). Genetic inhibition of CRMP2 phosphorylation at serine 522 promotes axonal regeneration after optic nerve injury. Scientific Reports, 9(1), 7188. https:\/\/doi.org\/10.1038\/s41598-019-43658-w","journal-title":"Scientific Reports"},{"issue":"12","key":"8778_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201800437","volume":"15","author":"MF Lawal","year":"2018","unstructured":"Lawal, M. F., Olotu, F. A., Agoni, C., & Soliman, M. E. (2018). Exploring the C-terminal tail dynamics: Structural and molecular perspectives into the therapeutic activities of novel CRMP-2 inhibitors, naringenin and naringenin-7-O-glucuronide, in the treatment of Alzheimer\u2019s disease. Chemistry & Biodiversity, 15(12), e1800437. https:\/\/doi.org\/10.1002\/cbdv.201800437","journal-title":"Chemistry & Biodiversity"},{"issue":"5","key":"8778_CR17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s10792-017-0658-4","volume":"38","author":"STP Maurano","year":"2018","unstructured":"Maurano, S. T. P., Da Silva, D. J., \u00c1vila, M. P., & Magacho, L. (2018). Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer\u2019s disease. International Ophthalmology, 38(5), 1839\u20131844. https:\/\/doi.org\/10.1007\/s10792-017-0658-4","journal-title":"International Ophthalmology"},{"issue":"6","key":"8778_CR18","doi-asserted-by":"publisher","first-page":"M110.000042","DOI":"10.1074\/mcp.M110.000042","volume":"10","author":"KN Menon","year":"2011","unstructured":"Menon, K. N., Steer, D. L., Short, M., Petratos, S., Smith, I., & Bernard, C. C. A. (2011). A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases. Molecular & Cellular Proteomics, 10(6), M110.000042. https:\/\/doi.org\/10.1074\/mcp.M110.000042","journal-title":"Molecular & Cellular Proteomics"},{"key":"8778_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fncel.2020.00188","volume":"14","author":"F Nakamura","year":"2020","unstructured":"Nakamura, F., Ohshima, T., & Goshima, Y. (2020). Collapsin response mediator proteins: Their biological functions and pathophysiology in neuronal development and regeneration. Frontiers in Cellular Neuroscience, 14, 188. https:\/\/doi.org\/10.3389\/fncel.2020.00188","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"7","key":"8778_CR20","first-page":"1940","volume":"41","author":"R Naskar","year":"2000","unstructured":"Naskar, R., Vorwerk, C. K., & Dreyer, E. B. (2000). Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Investigative Ophthalmology & Visual Science, 41(7), 1940\u20131944.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"8778_CR21","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/brain\/aws100","volume":"135","author":"S Petratos","year":"2012","unstructured":"Petratos, S., Ozturk, E., Azari, M. F., Kenny, R., Young Lee, J., Magee, K. A., Harvey, A. R., McDonald, C., Taghian, K., Moussa, L., Mun Aui, P., Siatskas, C., Litwak, S., Fehlings, M. G., Strittmatter, S. M., & Bernard, C. C. A. (2012). Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain, 135(6), 1794\u20131818. https:\/\/doi.org\/10.1093\/brain\/aws100","journal-title":"Brain"},{"issue":"3","key":"8778_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A. (2006). The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology, 90(3), 262\u2013267. https:\/\/doi.org\/10.1136\/bjo.2005.081224","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"8778_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41419-019-1365-z","volume":"10","author":"H Sano","year":"2019","unstructured":"Sano, H., Namekata, K., Kimura, A., Shitara, H., Guo, X., Harada, C., Mitamura, Y., & Harada, T. (2019). Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma. Cell Death & Disease, 10(2), 75. https:\/\/doi.org\/10.1038\/s41419-019-1365-z","journal-title":"Cell Death & Disease"},{"issue":"17","key":"8778_CR24","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1523\/JNEUROSCI.0730-10.2010","volume":"30","author":"R Seitz","year":"2010","unstructured":"Seitz, R., Hackl, S., Seibuchner, T., Tamm, E. R., & Ohlmann, A. (2010). Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt\/\u03b2-catenin signaling pathway and the induction of neuroprotective growth factors in M\u00fcller cells. The Journal of Neuroscience, 30(17), 5998\u20136010. https:\/\/doi.org\/10.1523\/JNEUROSCI.0730-10.2010","journal-title":"The Journal of Neuroscience"},{"key":"8778_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2020.100777","volume":"23","author":"T Tanaka-Gonome","year":"2020","unstructured":"Tanaka-Gonome, T., Xie, Y., Yamauchi, K., Maeda-Monai, N., Tanabu, R., Kudo, T., & Nakazawa, M. (2020). The protective effect of astaxanthin on the ganglion cell complex in glutamate\/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography. Biochemistry and Biophysics Reports, 23, 100777. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100777","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"11","key":"8778_CR26","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham, Y.-C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C.-Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology, 121(11), 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"issue":"2","key":"8778_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2443.2005.00827.x","volume":"10","author":"Y Uchida","year":"2005","unstructured":"Uchida, Y., Ohshima, T., Sasaki, Y., Suzuki, H., Yanai, S., Yamashita, N., Nakamura, F., Takei, K., Ihara, Y., Mikoshiba, K., Kolattukudy, P., Honnorat, J., & Goshima, Y. (2005). Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3\u03b2 phosphorylation of CRMP2: Implication of common phosphorylating mechanism underlying axon guidance and Alzheimer\u2019s disease: Sema3A signalling and Alzheimer\u2019s disease. Genes to Cells, 10(2), 165\u2013179. https:\/\/doi.org\/10.1111\/j.1365-2443.2005.00827.x","journal-title":"Genes to Cells"},{"issue":"5","key":"8778_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/npp.2010.245","volume":"36","author":"C-Y Wang","year":"2011","unstructured":"Wang, C.-Y., Zheng, W., Wang, T., Xie, J.-W., Wang, S.-L., Zhao, B.-L., Teng, W.-P., & Wang, Z.-Y. (2011). Huperzine A activates Wnt\/\u03b2-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology, 36(5), 1073\u20131089. https:\/\/doi.org\/10.1038\/npp.2010.245","journal-title":"Neuropsychopharmacology"},{"issue":"9422","key":"8778_CR29","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb, R. N., & Khaw, P. T. (2004). Primary open-angle glaucoma. The Lancet, 363(9422), 1711\u20131720. https:\/\/doi.org\/10.1016\/S0140-6736(04)16257-0","journal-title":"The Lancet"},{"issue":"4","key":"8778_CR30","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1523\/JNEUROSCI.5563-11.2012","volume":"32","author":"N Yamashita","year":"2012","unstructured":"Yamashita, N., Ohshima, T., Nakamura, F., Kolattukudy, P., Honnorat, J., Mikoshiba, K., & Goshima, Y. (2012). Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization. The Journal of Neuroscience, 32(4), 1360\u20131365. https:\/\/doi.org\/10.1523\/JNEUROSCI.5563-11.2012","journal-title":"The Journal of Neuroscience"},{"key":"8778_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fphar.2017.00340","volume":"8","author":"Z Yang","year":"2017","unstructured":"Yang, Z., Kuboyama, T., & Tohda, C. (2017). A systematic strategy for discovering a therapeutic drug for Alzheimer\u2019s disease and its target molecule. Frontiers in Pharmacology, 8, 340. https:\/\/doi.org\/10.3389\/fphar.2017.00340","journal-title":"Frontiers in Pharmacology"},{"issue":"16","key":"8778_CR32","doi-asserted-by":"publisher","first-page":"9761","DOI":"10.1074\/jbc.273.16.9761","volume":"273","author":"H Yoshida","year":"1998","unstructured":"Yoshida, H., Watanabe, A., & Ihara, Y. (1998). Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer\u2019s disease. Journal of Biological Chemistry, 273(16), 9761\u20139768. https:\/\/doi.org\/10.1074\/jbc.273.16.9761","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"8778_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.21037\/atm-20-8093","volume":"9","author":"P Yu","year":"2021","unstructured":"Yu, P., Dong, W.-P., Tang, Y.-B., Chen, H.-Z., Cui, Y.-Y., & Bian, X.-L. (2021). Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: A promising agent for the treatment of glaucoma. Annals of Translational Medicine, 9(4), 332\u2013332. https:\/\/doi.org\/10.21037\/atm-20-8093","journal-title":"Annals of Translational Medicine"},{"issue":"12","key":"8778_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tips.2006.10.004","volume":"27","author":"HY Zhang","year":"2006","unstructured":"Zhang, H. Y., & Tang, X. C. (2006). Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease. Trends in Pharmacological Sciences, 27(12), 619\u2013625. https:\/\/doi.org\/10.1016\/j.tips.2006.10.004","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"8778_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41398-020-0753-6","volume":"10","author":"W-N Zhao","year":"2020","unstructured":"Zhao, W.-N., Tobe, B. T. D., Udeshi, N. D., Xuan, L. L., Pernia, C. D., Zolg, D. P., Roberts, A. J., Mani, D., Blumenthal, S. R., Kurtser, I., Patnaik, D., Gaisina, I., Bishop, J., Sheridan, S. D., Lalonde, J., Carr, S. A., Snyder, E. Y., & Haggarty, S. J. (2020). Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion. Translational Psychiatry, 10(1), 76. https:\/\/doi.org\/10.1038\/s41398-020-0753-6","journal-title":"Translational Psychiatry"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-024-08778-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-024-08778-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-024-08778-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T15:49:26Z","timestamp":1735660166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-024-08778-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8778"],"URL":"https:\/\/doi.org\/10.1007\/s12017-024-08778-1","relation":{},"ISSN":["1559-1174"],"issn-type":[{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13"}}